SCHEMBL5847174

SCHEMBL5847174

Cc1nc(Cl)c(Cl)n1CCCCN1CCC(O)(c2ccc(F)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 15/20 0.57
DRD3 P35462 6/20 0.57
HTR1A P08908 4/20 0.57
DRD1 P21728 4/20 0.57
DRD5 P21918 4/20 0.57
SLC6A2 P23975 4/20 0.57
HTR2A P28223 4/20 0.57
SLC6A4 P31645 4/20 0.57
HTR7 P34969 4/20 0.57
HRH1 P35367 4/20 0.57
HTR2B P41595 4/20 0.57
SIGMAR1 Q99720 4/20 0.53
SLC6A3 Q01959 2/20 0.53
LMNA P02545 1/20 0.53
MEN1 O00255 1/20 0.52
CACNA1F O60840 1/20 0.52
KCNK2 O95069 1/20 0.52
ABCB11 O95342 1/20 0.52
CYP1A2 P05177 1/20 0.52
ADRB2 P07550 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159869 0.91 CCR1 (0.50) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL5846508 0.91 CCR3 (0.56) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL5848271 0.89 SIGMAR1 (0.53) DRD2DRD3HTR1AHTR2ASLC6A4
SCHEMBL5848902 0.81 OPRL1 (0.54) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL8010420 0.80 DRD2 (0.72) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL5846506 0.80 DRD2 (0.50) DRD2DRD3HTR1AHTR2ASLC6A4
SCHEMBL9053834 0.78 DRD2 (0.50) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL8570792 0.75 DRD2 (0.65) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL4060617 0.73 DRD2 (1.00) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL7665773 0.73 DRD2 (0.65) DRD2DRD3HTR1ADRD1DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39113-E1 Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2006-05-30 US claimed
EP-0721455-B9 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2005-04-20 EP claimed
EP-1097698-B1 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN ESTEVE LABOR DR (ES) 2003-05-07 EP claimed
EP-0721455-B1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2002-12-11 EP claimed
EP-1097698-A2 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-05-09 EP claimed
EP-0721455-A1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1996-07-17 EP claimed
WO-1996004287-A1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1996-02-15 WO claimed